3.2. QL Decreased Plasma Levels of NT-ProBNP, TNF-α, and TGF-β1, Reduced LVMI, and Alleviated LV Hypertrophy, Fibrosis, and Apoptosis. This evidence concerns the gene TNF and fibrosis.